<DOC>
	<DOCNO>NCT01471496</DOCNO>
	<brief_summary>The purpose study determine whether prophylactic injection therapy reduce recurrent bleed rate duodenal ulcer endoscopic stigmata recent bleeding .</brief_summary>
	<brief_title>Prophylactic Injection Therapy Reduces Recurrent Bleeding In Forrest Type IIb Duodenal Ulcers</brief_title>
	<detailed_description>The benefit endoscopic therapy ulcer adherent clot surface still uncertain . A prophylactic injection therapy may reduce recurrent bleed rate group patient endoscopic stigma recent bleeding . This type ulcer name type IIb duodenal ulcer accord Forrest 's classification , They cary risk bleed recurrence 36 percent report previously may 12 fold increasement morbidity mortality case . A prophylactic endoscopic injection therapy may reduce risk recurrent bleed group patient .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Duodenal Ulcer</mesh_term>
	<criteria>Endoscopic diagnose Forrest type 2b duodenal ulcer . Patients onset Upper Gastrointestinal system bleed symptom exceed 24 hour index endoscopy . Patients hemodynamic instability : systolic blood pressure 90 mm/hg , heart rate 110/min Demonstration hemoglobin fall 2 g/dl two hour . Patients coexist ulcer elsewhere duodenum . Patients anticoagulant therapy Aspirin .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>duodenal ulcer</keyword>
	<keyword>upper gastrointestinal system bleed</keyword>
	<keyword>injection therapy</keyword>
</DOC>